Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival.
Journal article
Whitburn J. et al, (2022), Sci Adv, 8
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer.
Journal article
Sjoberg HT. et al, (2021), Br J Cancer, 125, 534 - 546
A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease.
Journal article
Erickson A. et al, (2021), Eur Urol Oncol, 4, 358 - 369
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review.
Journal article
Farolfi A. et al, (2021), Eur Urol Oncol
Use of intraoperative fluorescence to enhance robot-assisted radical prostatectomy.
Journal article
Rajakumar T. et al, (2021), Future Oncol, 17, 1083 - 1095
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.
Journal article
Huynh-Le M-P. et al, (2021), Nat Commun, 12
The effect of sample size on polygenic hazard models for prostate cancer.
Journal article
Karunamuni RA. et al, (2020), Eur J Hum Genet, 28, 1467 - 1475
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.
Journal article
Huynh-Le M-P. et al, (2020), Cancer Epidemiol Biomarkers Prev, 29, 1731 - 1738
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model.
Journal article
Philippou Y. et al, (2020), Br J Cancer, 123, 1089 - 1100
Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.
Journal article
Sathianathen NJ. et al, (2020), Eur Urol, 78, 402 - 414
Glutamine deprivation alters the origin and function of cancer cell exosomes.
Journal article
Fan S-J. et al, (2020), EMBO J, 39
Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.
Journal article
Cappuccini F. et al, (2020), J Immunother Cancer, 8
Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.
Journal article
Rao SR. et al, (2020), J Mol Diagn, 22, 652 - 669
Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen.
Journal article
Harrison S. et al, (2020), Cancer Causes Control, 31, 431 - 449
Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit - the 'Fry-Turnbull' effect.
Journal article
Lovegrove CE. et al, (2020), BJU Int, 125, 484 - 486
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.
Journal article
Bryant RJ. et al, (2020), BJU Int, 125, 506 - 514
Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines).
Journal article
Beard DJ. et al, (2020), Lancet, 395, 828 - 838
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
Journal article
Neal DE. et al, (2020), Eur Urol, 77, 320 - 330
Transcriptomic and Functional Screens Reveal MicroRNAs That Modulate Prostate Cancer Metastasis.
Journal article
Rao SR. et al, (2020), Front Oncol, 10